Truist Financial Sticks to Their Buy Rating for Catalyst Pharma (CPRX)
Truist Financial analyst Joon Lee reiterated a Buy rating on Catalyst Pharma (CPRX – Research Report) today and set a price target of ...
Oppenheimer Keeps Their Buy Rating on Catalyst Pharma (CPRX)
Oppenheimer analyst Leland Gershell maintained a Buy rating on Catalyst Pharma (CPRX – Research Report) today and set a price target of ...